ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
XOMA Royalty Corporation

XOMA Royalty Corporation (XOMAO)

25.30
-0.06
(-0.24%)
終了 2月5日 6:00AM
25.30
0.00
( 0.00% )
プレマーケット: 6:00PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
25.30
買値
25.10
売値
25.48
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
25.30
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
11,782,723
配当利回り
8.28%
PER
-7.42
1 株当たり利益 (EPS)
-3.47
歳入
4.76M
純利益
-40.83M

XOMA Royalty Corporation について

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker XOMAO. The last closing price for XOMA Royalty was US$25.30. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 0.00 to US$ 0.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$298.10 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.42.

XOMAO 最新ニュース

XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

EMERYVILLE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

XOMAO - Frequently Asked Questions (FAQ)

What is the current XOMA Royalty share price?
The current share price of XOMA Royalty is US$ 25.30
How many XOMA Royalty shares are in issue?
XOMA Royalty has 11,782,723 shares in issue
What is the market cap of XOMA Royalty?
The market capitalisation of XOMA Royalty is USD 298.1M
What is the 1 year trading range for XOMA Royalty share price?
XOMA Royalty has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of XOMA Royalty?
The price to earnings ratio of XOMA Royalty is -7.42
What is the cash to sales ratio of XOMA Royalty?
The cash to sales ratio of XOMA Royalty is 63.69
What is the reporting currency for XOMA Royalty?
XOMA Royalty reports financial results in USD
What is the latest annual turnover for XOMA Royalty?
The latest annual turnover of XOMA Royalty is USD 4.76M
What is the latest annual profit for XOMA Royalty?
The latest annual profit of XOMA Royalty is USD -40.83M
What is the registered address of XOMA Royalty?
The registered address for XOMA Royalty is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the XOMA Royalty website address?
The website address for XOMA Royalty is www.xoma.com
Which industry sector does XOMA Royalty operate in?
XOMA Royalty operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
OPOFOld Point Financial Corporation
US$ 39.51
(58.99%)
4
TWINTwin Disc Inc
US$ 17.88
(58.93%)
155
IBACIB Acquisition Corporation
US$ 16.24
(58.90%)
2
SFHGSamfine Creation Holdings Group Ltd
US$ 1.57
(57.00%)
5.57M
ADSEADD TEC Energy PLC
US$ 23.39
(56.66%)
12
SBFGSB Finanical Group Inc
US$ 12.22
(-46.85%)
10
THRYThryv Holdings Inc
US$ 10.01
(-46.01%)
4
IROQIF Bancorp Inc
US$ 15.00
(-38.17%)
200
AURAAura Biosciences Inc
US$ 5.01
(-37.38%)
1
WMPNWilliam Penn Bancorporation
US$ 8.00
(-35.22%)
201
CYNCYNGN Inc
US$ 0.0796
(12.11%)
13.24M
SXTP60 Degrees Pharmaceuticals Inc
US$ 0.9063
(51.81%)
12.48M
UPCUniverse Pharmaceuticals Inc
US$ 0.3206
(18.78%)
6.77M
SFHGSamfine Creation Holdings Group Ltd
US$ 1.57
(57.00%)
5.57M
RIMEAlgorhythm Holdings Inc
US$ 0.0251
(2.87%)
5.02M

最近閲覧した銘柄

Delayed Upgrade Clock